Insuficencia cardíaca. Nuevos conceptos, nuevos medicamentos / Heart failure. New concepts, new medications
Rev. méd. Panamá
;
19(1): 1-7, Jan. 1994.
Article
in Spanish
| LILACS
| ID: lil-409995
RESUMO
It is possible, in our midst, to obtain a survival rate of 68% and a marked improvement in the functional capacity of patients with advanced cardiac insufficiency due to systolic myocardial dysfunction through the combined use of ACE inhibitors, diuretics and digitalis as the main therapeutic agents. Patients with cardiac failure due to atherosclerotic heart disease have a slight better prognosis than those whose failure is secondary to dilated idiopathic congestive cardiomyopathy. The incidence of arrhythmias, sudden death and peripheral embolism suggest that the use of Amiodarone as antiarrhythmic agent and of Warfarin as anticoagulant should be increased. Each of these agents was used in only 26% of our patients
Search on Google
Index:
LILACS (Americas)
Main subject:
Heart Failure
Type of study:
Diagnostic study
/
Observational study
/
Prognostic study
/
Risk factors
Limits:
Female
/
Humans
/
Male
Language:
Spanish
Journal:
Rev. méd. Panamá
Journal subject:
Medicine
Year:
1994
Type:
Article
Affiliation country:
Panama
Institution/Affiliation country:
Universidad de Panamá/PA
Similar
MEDLINE
...
LILACS
LIS